Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Chemotherapy and Stem Cell/Bone Marrow Rescue in Refractory Lymphoma
NCT00002461Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Apr 1988
- Primary completion
- Jul 1991
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of carmustine, etoposide, cisplatin and cyclophosphamide in Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Antitumor activity. Started Apr 1988; status: completed.
02
Drugs
carmustineetoposidecisplatincyclophosphamide
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00002461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002461.